Your browser doesn't support javascript.
loading
Immunogenicity and Efficacy of Zika Virus Envelope Domain III in DNA, Protein, and ChAdOx1 Adenoviral-Vectored Vaccines.
López-Camacho, César; De Lorenzo, Giuditta; Slon-Campos, Jose Luis; Dowall, Stuart; Abbink, Peter; Larocca, Rafael A; Kim, Young Chan; Poggianella, Monica; Graham, Victoria; Findlay-Wilson, Stephen; Rayner, Emma; Carmichael, Jennifer; Dejnirattisai, Wanwisa; Boyd, Michael; Hewson, Roger; Mongkolsapaya, Juthathip; Screaton, Gavin R; Barouch, Dan H; Burrone, Oscar R; Patel, Arvind H; Reyes-Sandoval, Arturo.
Affiliation
  • López-Camacho C; The Jenner Institute, Nuffield Department of Medicine, University of Oxford, The Henry Wellcome Building for Molecular Physiology, Roosevelt Drive, Oxford OX3 7BN, UK.
  • De Lorenzo G; Wellcome Centre for Human Genetics, Nuffield Department of Medicine, University of Oxford, Oxford OX3 7BN, UK.
  • Slon-Campos JL; MRC-University of Glasgow Centre for Virus Research, University of Glasgow, Glasgow G61 1QH, UK.
  • Dowall S; Molecular Immunology Group, International Centre for Genetic Engineering and Biotechnology, Padriciano 99, 34149 Trieste, Italy.
  • Abbink P; Public Health England, National Infection Service, Porton Down, Salisbury SP4 0JG, UK.
  • Larocca RA; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA.
  • Kim YC; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA.
  • Poggianella M; The Jenner Institute, Nuffield Department of Medicine, University of Oxford, The Henry Wellcome Building for Molecular Physiology, Roosevelt Drive, Oxford OX3 7BN, UK.
  • Graham V; Molecular Immunology Group, International Centre for Genetic Engineering and Biotechnology, Padriciano 99, 34149 Trieste, Italy.
  • Findlay-Wilson S; Public Health England, National Infection Service, Porton Down, Salisbury SP4 0JG, UK.
  • Rayner E; Public Health England, National Infection Service, Porton Down, Salisbury SP4 0JG, UK.
  • Carmichael J; Public Health England, National Infection Service, Porton Down, Salisbury SP4 0JG, UK.
  • Dejnirattisai W; MRC-University of Glasgow Centre for Virus Research, University of Glasgow, Glasgow G61 1QH, UK.
  • Boyd M; MRC-University of Glasgow Centre for Virus Research, University of Glasgow, Glasgow G61 1QH, UK.
  • Hewson R; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA.
  • Mongkolsapaya J; Public Health England, National Infection Service, Porton Down, Salisbury SP4 0JG, UK.
  • Screaton GR; Wellcome Centre for Human Genetics, Nuffield Department of Medicine, University of Oxford, Oxford OX3 7BN, UK.
  • Barouch DH; Dengue Haemorrhagic Fever Research Unit, Office for Research and Development, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok 10700, Thailand.
  • Burrone OR; Wellcome Centre for Human Genetics, Nuffield Department of Medicine, University of Oxford, Oxford OX3 7BN, UK.
  • Patel AH; Division of Medical Sciences, John Radcliffe Hospital, University of Oxford, Oxford OX3 9DU, UK.
  • Reyes-Sandoval A; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA.
Vaccines (Basel) ; 8(2)2020 Jun 16.
Article in En | MEDLINE | ID: mdl-32560145
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Vaccines (Basel) Year: 2020 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Vaccines (Basel) Year: 2020 Document type: Article Affiliation country: Country of publication: